Pope Francis (Credit: X)
Pope Francis injured his right arm after suffering a fall earlier this week. According to the Vatican, while the 88-year-old pontiff did not break his arm, a sling was put on as a precaution. This incident comes just weeks after another fall on December 7, where he hit his chin on a nightstand, resulting in another, visible bruise. The pope's health has been a topic of ongoing speculation due to his age and medical history, which includes long bouts of bronchitis and mobility challenges. Often seen using a wheelchair or a cane, Francis also uses a walker within the Vatican's Santa Marta hotel, where he resides. Notably, his frailty has brought renewed attention to the risks of falls among elderly individuals and the steps one must follow to mitigate such falls.
A study published in Frontiers in Aging Neurosciences people get older, the bone density in the lower back and thigh bone decreases significantly. This raises the risk of osteoporosis (OP). Therefore it becomes pivotal to pay early attention to nutrition, exercise ability, vitamin D levels, and uric acid levels in older individuals to prevent Ostreopsis and mitigate fall risks. The risk of falls and bone injuries among elderly individuals underscores the importance of preventive measures for maintaining bone health and minimizing fall risks.
Elderly, particularly menopausal women, require a daily calcium intake of 1,200 mg, divided into two or more doses. This can be achieved through dietary sources such as dairy and non-dairy products or through supplements like calcium carbonate and calcium citrate. However, total daily calcium intake should not exceed 2,500 mg to avoid potential health risks.
Vitamin D is essential for calcium absorption and bone mineralization. While sunlight exposure helps synthesize vitamin D, older individuals often require supplements due to reduced skin synthesis and the limited availability of foods. Fortified milk and supplements containing 200–600 IU of vitamin D daily are recommended, with higher doses required for those with deficiencies. Severe cases may necessitate high-dose treatments, such as 50,000 IU weekly for up to three months, along with regular monitoring of calcium and vitamin D levels.
Regular exercise is vital for preserving bone mass and reducing fall risk. Weight-bearing activities, strength training, and balance exercises like brisk walking or skipping can enhance bone density and improve coordination. Experts recommend at least 30 minutes of moderate physical activity most days of the week, supplemented by strength training twice weekly. For individuals unable to engage in standard exercise routines, alternatives like vibrating platforms may help maintain bone health.
Falls remain a leading cause of fractures among individuals over 60. Addressing contributing factors such as balance issues, vision problems, and environmental hazards can significantly reduce risks. Preventive measures include regular vision checks, minimizing medications causing dizziness, improving home safety (e.g., installing railings and removing loose rugs), and wearing rubber-soled footwear. Hip protectors may also help mitigate the impact of falls.
Credit: AI
Tiny plastic particles may be making their way into one of the body's most protected organs, the brain, according to new research. This has raised concerns about the long-term health effects of microplastic exposure, particularly on brain health.
In a study published in Nature Medicine, researchers found that microplastics and nanoplastics were present in brain tissue, with significantly higher concentrations than in liver and kidneys.
One of the most important findings is that these particles can cross the blood-brain barrier, a protective shield that normally blocks harmful substances from entering the brain.
The researchers analysed brain tissue samples collected over several years and observed that they contained seven to 30 times more plastic particles than other organs.
They also found an increase in brain plastic concentrations in more recent samples, reflecting the growing burden of plastic pollution worldwide in the last few years.
"Our data suggest a trend of increasing concentrations of micro- and nanoplastics in the brain," the study authors wrote. They stressed that the findings do not prove these particles cause disease.
The researchers also reported higher concentrations of plastic particles in brain tissue from people diagnosed with dementia.
However, they cautioned that the study only identified an association and cannot determine whether microplastics contribute to dementia or whether brains diseased with dementia simply accumulate more particles.
Scientists are still trying to understand how these particles do harm once they reach the brain. Proposed theories include triggering inflammation, disrupting communication between nerve cells, or affecting blood flow, but none have yet been confirmed in humans.
Since nanoplastics are extremely small, researchers believe some may pass through the blood-brain barrier and become trapped in brain tissue.
The study found polyethylene, commonly used in food packaging and plastic bottles, was the most abundant type detected in the brain tissue.
Scientists emphasise that it is too early to conclude that microplastics directly damage the human brain.
"The findings are concerning, but they should not be interpreted as proof that microplastics cause neurological disease," the researchers emphasised. More studies are needed to determine whether the particles themselves are harmful or simply markers of environmental exposure.
Also read: Dementia Progression Observed To Slow Down When You Do This Exercise 3 Times A Week
While eliminating exposure entirely is nearly impossible, experts recommend practical steps that may lower intake:
The study adds to mounting evidence that microplastics are no longer just an environmental issue. They are increasingly being detected throughout the human body, including the blood, lungs, placenta and now the brain.
Credit: AI
A new study by the US Centers for Disease Control and Prevention (CDC) has found that nearly one in three patients who were hospitalised were diagnosed with invasive mould disease (IMD) died during their hospital stay.
The findings highlighted the urgent need for better surveillance, hygiene, early diagnosis, and greater awareness among healthcare professionals.
The findings come from the surveillance study of invasive mould infections conducted by the CDC across four hospitals in Atlanta and Georgia, between 2020 and 2024.
Researchers identified 499 confirmed cases of invasive mould disease during the five-year study period. Around 33% of these patients died while hospitalised, while the overall 90-day mortality rate reached 45%.
Nearly half of the patients needed intensive care, and about 50% needed ventilation, highlighting just how severe these infections can turn.
Patients who had a recent or current COVID-19 infection were found to be even worse. Their 90-day mortality rate was 66%, compared with 41% among patients without COVID-19.
"Our findings demonstrate that invasive mold disease is associated with substantial illness and death," the CDC researchers wrote, adding that active surveillance can help improve understanding of how common these infections are and guide prevention efforts.
Also read: DR Congo Ebola Outbreak Becomes World’s Second Largest As Death Toll Surpasses 1,500
Unlike the mould that grows on damp walls or spoiled food, invasive mould disease occurs when fungal spores enter the body through the lungs, wounds, or contaminated medical equipment and spread into deep tissues, blood vessels, or organs.
The infections are most commonly caused by fungi such as Aspergillus, Mucorales, Fusarium, and Scedosporium. Once inside the body, they can rapidly become life-threatening if not diagnosed and treated early.
Also read: Vibrio Vulnificus: US Records First Flesh-eating Bacteria Death Of 2026
The disease rarely affects healthy individuals. Instead, it primarily targets people whose immune systems are already weakened, including:
Also read: Donald Trump Urges RFK Jr. To Accelerate Childhood Vaccine Rollback
One of the biggest challenges is that invasive mould disease is not a nationally reportable disease in the United States, meaning health authorities do not routinely collect nationwide data on cases. Researchers believe the actual burden may therefore be underestimated.
The CDC authors noted that active surveillance is essential to estimate disease incidence, identify outbreaks, and improve patient outcomes. They also highlighted that patients with COVID-19 experienced significantly more severe disease, suggesting clinicians should remain vigilant for fungal complications in critically ill patients.
Outside experts have also warned that factors such as climate change, extreme weather events, an ageing population, and rising antifungal drug resistance could contribute to an increase in serious fungal infections in the coming years.
Although invasive mould infections remain relatively uncommon, the study shows they carry an alarmingly high risk of severe illness and death among vulnerable patients. Researchers say increasing awareness, recognising symptoms early, improving hospital surveillance, and developing faster diagnostic tools could help identify infections sooner and improve survival.
Credit: AI
India's food safety regulator has banned the sale of select whisky and rum products produced by some of the country's biggest liquor companies, including Diageo India's United Spirits.
FSSAI's move comes after they found artificial or "nature-identical" flavouring that allegedly violates Indian food standards.
Among the affected products are United Spirits' Antiquity Blue Whisky and Royal Challenge Whisky manufactured in Madhya Pradesh, Inbrew's Bagpiper Deluxe Whisky and Old Cask Deluxe XXX Rum, as well as three variants of Old Monk produced by Mohan Rocky Springwater in Maharashtra.
It is still unclear whether the restrictions apply only to products manufactured at these specific facilities or to the brands nationwide.
The Food Safety and Standards Authority of India (FSSAI) said laboratory tests found that certain products manufactured by United Spirits, Inbrew Beverages and Mohan Rocky Springwater contained external artificial or nature-identical flavouring substances intended to recreate the taste and aroma of whisky or rum, instead of relying on traditional production methods.
According to the regulator, the use of natural flavouring substances in alcoholic beverages is permitted but manufacturers cannot add whisky flavour to whisky or rum flavour to rum.
"There is no internationally recognized manufacturing practice whereby rum flavour is added to rum or whisky flavour is added to whisky," FSSAI said in its statement.
The regulator added that these practices could bypass proper maturation and reduce reliance on ingredients traditionally used to develop flavour, including molasses, malt and grapes.
FSSAI classified the tested products as "sub-standard due to the presence of external artificial or nature-identical flavours in the product."
While Diageo India, Inbrew Beverages and Mohan Rocky Springwater did not immediately issue public responses to media queries, Reuters reported that some industry executives believe the use of flavouring does not violate existing Indian regulations.
Also read: You Can No Longer Buy Medicines Containing More Than 12% Alcohol Over the Counter: Health Ministry
Nature-identical flavouring substances are chemically synthesised compounds created to replicate the flavours naturally found in foods or beverages.
Although they may be seem same like the naturally occurring compounds, regulators determine whether they can be used in specific products based on food standards.
In this case, FSSAI's objection is not to all flavourings, but specifically to the addition of whisky or rum flavouring to beverages marketed as whisky or rum.
They argue that the flavour should develop naturally through the approved manufacturing and ageing process.
India is among the world's largest alcohol markets, with annual sales estimated at around $40 billion, and United Spirits, owned by global drinks giant Diageo, is the country's largest liquor company by market share.
The affected products are widely consumed because they are significantly more affordable than the imported spirits.
The latest action also signals FSSAI's bigger effort to tighten regulations of the food and beverage industry. In recent weeks, the regulator has also intensified scrutiny of products marketed as energy drinks and other packaged foods over labelling and compliance issues.
© 2024 Bennett, Coleman & Company Limited